Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 4
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Dexacortone vet 0.5 mg V/DCP/17/0051 Le Vet Beheer B.V., Nīderlande QH02AB02 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Dexamethasone
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;Genera d.d., Horvātija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (23-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0051-01 1 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0051-02 2 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0051-03 3 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0051-04 4 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0051-05 5 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0051-06 6 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0051-07 7 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0051-08 8 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0051-09 9 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0051-10 10 PVH/PVDH alumīnija blisteris, 10 tablete -
Dexacortone vet 2 mg V/DCP/17/0052 Le Vet Beheer B.V., Nīderlande QH02AB02 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Dexamethasone
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (23-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0052-01 1 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0052-02 2 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0052-03 3 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0052-05 4 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0052-06 5 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0052-07 6 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0052-08 7 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0052-09 8 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0052-10 9 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/17/0052-11 10 PVH/PVDH alumīnija blisteris, 10 tablete -
Cepesedan 10 mg/ml V/MRP/07/1690 CP-Pharma Handelsgesellschaft GmbH, Vācija QN05CM90 cattle; horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Detomidine hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP Pharma GmbH, Vācija
Date of authorisation/renewal: 03-Aug-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Feb-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Feb-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Feb-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/07/1690-01 10 mg/ml 1 Stikla pudelīte, 5 ml -
V/MRP/07/1690-02 10 mg/ml 5 Stikla pudelīte, 5 ml -
V/MRP/07/1690-03 10 mg/ml 1 Stikla pudelīte, 20 ml -
V/MRP/07/1690-04 10 mg/ml 5 Stikla pudelīte, 20 ml -
Advantage 40 mg V/NRP/01/1363 Elanco Animal Health GmbH, Vācija QP53AX17 small cats Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Bayer HealthCare AG, Vācija
Date of authorisation/renewal: 26-Feb-2013
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Jun-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Jun-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI” (06-Jun-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/01/1363-01 40 mg 2 Polipropilēna pipete, 0,4 ml -
V/NRP/01/1363-02 40 mg 3 Polipropilēna pipete, 0,4 ml -
V/NRP/01/1363-03 40 mg 4 Polipropilēna pipete, 0,4 ml -
V/NRP/01/1363-04 40 mg 6 Polipropilēna pipete, 0,4 ml -
Triquest 333 mg/ml + 67 mg/ml - V/DCP/24/0058 Alfasan Nederland BV, Nīderlande QJ01EW10 horses Vairāk

Medicinal product information

Pharmaceutical form: suspension for oral use
International name (active substance): Sulfadiazine, Trimethoprim
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 26-Aug-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (14-May-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (14-May-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (14-May-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0058-01 1 ABPE pudele, 225 ml -
V/DCP/24/0058-02 1 ABPE pudele, 450 ml -
V/DCP/24/0058-03 1 ABPE pudele, 90 ml -
Fiprotec 50 mg V/DCP/14/0019 Beaphar B.V., Nīderlande QP53AX15 cats Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Laboratorios Calier, S.A., Spānija;Beaphar BV, Nīderlande
Date of authorisation/renewal: 08-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0019-01 50 mg 1 Pipete, 1 deva -
V/DCP/14/0019-02 50 mg 2 Pipete, 1 deva -
V/DCP/14/0019-03 50 mg 3 Pipete, 1 deva -
V/DCP/14/0019-04 50 mg 6 Pipete, 1 deva -
V/DCP/14/0019-07 50 mg 4 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0019-08 50 mg 1 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0019-09 50 mg 2 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0019-10 50 mg 3 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0019-11 50 mg 6 Pipete alumīnija blisterī, 1 deva -
Bovaclox DC - V/NRP/98/0802 Norbrook Laboratories (Ireland) Limited, Īrija QJ51RC26 cows Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Cloxacillin benzathine, Ampicillin trihydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Norbrook Manufacturing Limited, Īrija
Date of authorisation/renewal: 08-Dec-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/98/0802-01 24 Injektors, 1 deva -
V/NRP/98/0802-02 120 Injektors, 1 deva -
V/NRP/98/0802-03 120 Injektors, 1 deva -
Dophexine 20 mg/g V/DCP/20/0047 Dopharma Research B.V., Nīderlande QR05CB02 cattle; pigs; ducks; turkeys; chickens Vairāk

Medicinal product information

Pharmaceutical form: powder for use in drinking water/ milk
International name (active substance): Bromhexine hydrohloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Dopharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (20-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0047-01 20 mg/g 1 Polipropilēna konteiners, 1 kg -
V/DCP/20/0047-02 20 mg/g 1 Kompozītmateriāla kārba, 1 kg -
V/DCP/20/0047-03 20 mg/g 1 Polipropilēna spainis, 1 kg -
V/DCP/20/0047-04 20 mg/g 1 Polipropilēna spainis, 2,5 kg -
V/DCP/20/0047-05 20 mg/g 1 Polipropilēna spainis, 5 kg -
LV Intermectin 10 mg/ml V/NRP/12/0041 Interchemie Werken De Adelaar Eesti AS, Igaunija QP54AA01 cattle; pigs; sheep; goats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Ivermectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Interchemie Werken De Adelaar Eesti AS, Igaunija
Date of authorisation/renewal: 04-Jul-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Jun-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Jun-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Jun-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/12/0041-01 10 mg/ml 1 Stikla pudele ar Al vāciņu, 100 ml -
V/NRP/12/0041-02 10 mg/ml 1 Stikla pudele ar Al vāciņu, 50 ml -
V/NRP/12/0041-03 10 mg/ml 1 Stikla pudele ar Al vāciņu, 10 ml -
V/NRP/12/0041-04 10 mg/ml 1 Stikla pudele ar Al vāciņu, 500 ml -
V/NRP/12/0041-05 10 mg/ml 1 PET pudele, 50 ml -
V/NRP/12/0041-06 10 mg/ml 1 PET pudele, 100 ml -
V/NRP/12/0041-07 10 mg/ml 1 PET pudele, 10 ml -
V/NRP/12/0041-08 10 mg/ml 1 PET pudele, 500 ml -
K1 KEYVIT 50 mg V/DCP/21/0064 NEXTMUNE ITALY S.R.L., Itālija QB02BA01 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): PHYTOMENADIONE
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Jan-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Jan-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (12-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/21/0064-01 50 mg 1 Blisteris, 7 tablete -
V/DCP/21/0064-02 50 mg 2 Blisteris, 7 tablete -
V/DCP/21/0064-03 50 mg 3 Blisteris, 7 tablete -
V/DCP/21/0064-04 50 mg 4 Blisteris, 7 tablete -
V/DCP/21/0064-05 50 mg 5 Blisteris, 7 tablete -
V/DCP/21/0064-06 50 mg 12 Blisteris, 7 tablete -
Atonyl 1.5 mg/ml V/DCP/19/0067 Cenavisa S.L, Spānija QN07AA01 cattle; sheep; goats; horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Neostigmine methylsulfate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Cenavisa S.L, Spānija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (01-Apr-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (01-Apr-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (01-Apr-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0067-01 1,5 mg/ml 1 Stikla flakons, 40 ml -
Alvegesic vet. 10 mg/ml V/MRP/11/0044 V.M.D. n.v., Beļģija QN02AF01 horses; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Butorphanol tartrate
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Sanochemia Pharmazeutica AG, Austrija
Date of authorisation/renewal: 08-Apr-2014
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (31-Jan-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (31-Jan-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (18-Jun-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/11/0044-01 10 mg/ml 1 Stikla flakons, 10 ml -
LidoBel 20 mg/ml V/DCP/18/0037 Bela-pharm GmbH&Co.KG, Vācija QN01BB02 horses; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Lidocaine hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bela-pharm GmbH&Co.KG, Vācija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (29-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (29-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (29-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0037-01 1 Stikla flakons, 100 ml -
V/DCP/18/0037-02 1 Stikla flakons, 250 ml -
V/DCP/18/0037-03 12 Stikla flakons, 100 ml -
V/DCP/18/0037-04 12 Stikla flakons, 250 ml -
BIOSUIS ParvoEry - V/DCP/19/0015 Bioveta, a.s., Čehija QI09AL01 pigs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Porcine parvovirus, inactivated, strain CAPM V198, S-27, Erysipelothrix rhusiopathiae inactivated, serotype 2, strain 2-64
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (07-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0015-01 1 Stikla flakons, 10 ml -
V/DCP/19/0015-02 10 Stikla flakons, 10 ml -
V/DCP/19/0015-03 1 Stikla flakons, 50 ml -
V/DCP/19/0015-04 1 Plastmasas flakons, 50 ml -
V/DCP/19/0015-05 1 Stikla flakons, 100 ml -
V/DCP/19/0015-06 1 Plastmasas flakons, 100 ml -
V/DCP/19/0015-07 1 Plastmasas flakons, 250 ml -
Hyogen - V/DCP/15/0017 Ceva Sante Animale', Francija QI09AB13 pigs Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Inactivated Mycoplasma hyopneumoniae, strain 2940
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
Date of authorisation/renewal: 27-May-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Dec-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Dec-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/15/0017-01 1 PET pudele, 50 ml -
V/DCP/15/0017-02 1 PET pudele, 100 ml -
V/DCP/15/0017-03 1 PET pudele, 250 ml -
V/DCP/15/0017-04 5 PET pudele, 50 ml -
V/DCP/15/0017-05 5 PET pudele, 100 ml -
V/DCP/15/0017-06 5 PET pudele, 250 ml -
V/DCP/15/0017-07 1 PET pudele, 200 ml -
V/DCP/15/0017-08 5 PET pudele, 200 ml -
V/DCP/15/0017-09 1 PET pudele, 100 deva -
V/DCP/15/0017-10 5 PET pudele, 100 deva -
Altresyn 4 mg/ml V/MRP/08/1610 Ceva Sante Animale', Francija QG03DX90 pigs Vairāk

Medicinal product information

Pharmaceutical form: solution for oral use
International name (active substance): Altrenogest
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva Sante Animale, Francija
Date of authorisation/renewal: 23-Dec-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Nov-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Nov-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/08/1610-01 4 mg/ml 1 Flakons, 360 ml -
V/MRP/08/1610-02 4 mg/ml 3 Flakons, 360 ml -
V/MRP/08/1610-03 4 mg/ml 1 Konteiners, 540 ml -
V/MRP/08/1610-04 4 mg/ml 1 Konteiners, 1080 ml -
Vetoryl 20 mg V/SRP/25/0025 Dechra Regulatory B.V., Nīderlande QH02CA01 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Trilostane
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 24-Apr-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: SRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Apr-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Apr-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Apr-2025)

Products

ID Strength Package size Primary packaging Labelling
V/SRP/25/0025-01 1 PA/Al/PVH//Al blisteris, 10 tablete -
V/SRP/25/0025-02 3 PA/Al/PVH//Al blisteris, 10 tablete -
V/SRP/25/0025-03 5 PA/Al/PVH//Al blisteris, 10 tablete -
V/SRP/25/0025-04 6 PA/Al/PVH//Al blisteris, 10 tablete -
V/SRP/25/0025-05 10 PA/Al/PVH//Al blisteris, 10 tablete -
Vetoryl 30 mg V/SRP/25/0026 Dechra Regulatory B.V., Nīderlande QH02CA01 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Trilostane
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 24-Apr-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: SRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Apr-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Apr-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Apr-2025)

Products

ID Strength Package size Primary packaging Labelling
V/SRP/25/0026-01 1 PA/Al/PVH blisteris, 10 tablete -
V/SRP/25/0026-02 3 PA/Al/PVH blisteris, 10 tablete -
V/SRP/25/0026-03 5 PA/Al/PVH blisteris, 10 tablete -
V/SRP/25/0026-04 6 PA/Al/PVH blisteris, 10 tablete -
V/SRP/25/0026-05 10 PA/Al/PVH blisteris, 10 tablete -
Nextmune - V/DCP/20/0046 Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija QI01AD09 chickens Vairāk

Medicinal product information

Pharmaceutical form: concentrate and solvent for suspension for injection
International name (active substance): Live attenuated IBD virus, Serotype 1, strain G-61 (Winterfield 2512)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Jan-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Jan-2025)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (27-Jan-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0046-01 1 Stikla ampula (5ml), 2000 deva -
V/DCP/20/0046-02 1 Stikla ampula (5ml), 4000 deva -
V/DCP/20/0046-03 1 Stikla ampula (5ml), 8000 deva -
V/DCP/20/0046-04 1 Stikla ampula (2ml), 2000 deva -
V/DCP/20/0046-05 1 Stikla ampula (2ml), 4000 deva -
V/DCP/20/0046-06 1 Maiss (šķīdinātājs), 400 ml -
V/DCP/20/0046-07 1 Maiss (šķīdinātājs), 800 ml -
V/DCP/20/0046-08 1 Maiss (šķīdinātājs), 1000 ml -
V/DCP/20/0046-09 1 Maiss (šķīdinātājs), 1200 ml -
V/DCP/20/0046-10 1 Maiss (šķīdinātājs), 1600 ml -
Frontline Combo Dog S - V/NRP/03/1586 Boehringer Ingelheim Animal Health France SCS , Francija QP53AX65 dogs (under 10kg) Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil, S-Methoprene
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Boehringer Ingelheim Animal Health France SCS., Francija
Date of authorisation/renewal: 15-Jul-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (28-May-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (28-May-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (15-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/03/1586-02 3 Pipete, 0,67 ml -
V/NRP/03/1586-03 6 Pipete, 0,67 ml -
V/NRP/03/1586-10 1 Pipete, 0,67 ml -

3082 records

© Food and veterinary service · 2026 Cookies policy